Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 3
1967 9
1968 6
1969 8
1970 5
1971 3
1972 6
1973 6
1974 7
1975 11
1976 5
1977 8
1978 23
1979 13
1980 24
1981 15
1982 24
1983 30
1984 18
1985 23
1986 29
1987 33
1988 43
1989 38
1990 52
1991 65
1992 72
1993 102
1994 78
1995 128
1996 161
1997 128
1998 182
1999 180
2000 196
2001 173
2002 168
2003 175
2004 139
2005 152
2006 127
2007 145
2008 111
2009 90
2010 95
2011 116
2012 123
2013 112
2014 109
2015 110
2016 83
2017 82
2018 84
2019 93
2020 84
2021 90
2022 83
2023 65
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

4,151 results

Results by year

Filters applied: . Clear all
Page 1
Immunologic effect and clinical impact of erythromycin in septic patients: A randomized clinical trial.
Trifi A, Tlili B, Kallel Sellami M, Feki M, Mehdi A, Seghir E, Messaoud L, Abdellatif S, Ben Lakhal S. Trifi A, et al. J Crit Care. 2024 Jun;81:154533. doi: 10.1016/j.jcrc.2024.154533. Epub 2024 Feb 14. J Crit Care. 2024. PMID: 38359518 Clinical Trial.
To investigate the potential regulatory effect of erythromycin added to standard care in septic patients on sepsis biomarkers and clinical outcome. ...Erythromycin addition had no beneficial effects on the TNF/IL-10 ratio or mortality (51% vs. 47%, p = 0.62). ...
To investigate the potential regulatory effect of erythromycin added to standard care in septic patients on sepsis biomarkers and cli …
A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
Schachner L, Pestana A, Kittles C. Schachner L, et al. J Am Acad Dermatol. 1990 Mar;22(3):489-95. doi: 10.1016/0190-9622(90)70069-t. J Am Acad Dermatol. 1990. PMID: 2138180 Free article. Clinical Trial.
In the 92 patients who completed this study (48 receiving erythromycin-zinc and 44 receiving clindamycin), no serious topical or systemic side effects were reported. ...The superiority of the erythromycin-zinc formulation may be due to the increased (4%) erythrom
In the 92 patients who completed this study (48 receiving erythromycin-zinc and 44 receiving clindamycin), no serious topical or syst …
Campylobacter cholecystitis.
Udayakumar D, Sanaullah M. Udayakumar D, et al. Int J Med Sci. 2009 Dec 1;6(6):374-5. doi: 10.7150/ijms.6.374. Int J Med Sci. 2009. PMID: 19960123 Free PMC article. Clinical Trial.
Erythromycin for Gastric Emptying in Patients Undergoing General Anesthesia for Emergency Surgery: A Randomized Clinical Trial.
Czarnetzki C, Elia N, Frossard JL, Giostra E, Spahr L, Waeber JL, Pavlovic G, Lysakowski C, Tramèr MR. Czarnetzki C, et al. JAMA Surg. 2015 Aug;150(8):730-7. doi: 10.1001/jamasurg.2015.0306. JAMA Surg. 2015. PMID: 26083537 Clinical Trial.
One patient receiving erythromycin vomited before induction of anesthesia. CONCLUSIONS AND RELEVANCE: In patients undergoing general anesthesia for emergency procedures, erythromycin administration increased the proportion with a clear stomach and decreased the acid …
One patient receiving erythromycin vomited before induction of anesthesia. CONCLUSIONS AND RELEVANCE: In patients undergoing general …
Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis.
Scaglione F. Scaglione F. Curr Med Res Opin. 1990;12(1):25-33. doi: 10.1185/03007999009111488. Curr Med Res Opin. 1990. PMID: 2140547 Clinical Trial.
In general, the severity of adverse events was greater for the patients treated with erythromycin, necessitating the discontinuation of therapy in 8 (6.7%) patients treated with erythromycin as opposed to 1 (0.8%) patient treated with clarithromycin. Although clarit …
In general, the severity of adverse events was greater for the patients treated with erythromycin, necessitating the discontinuation …
Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo.
Goldfarb J, Crenshaw D, O'Horo J, Lemon E, Blumer JL. Goldfarb J, et al. Antimicrob Agents Chemother. 1988 Dec;32(12):1780-3. doi: 10.1128/AAC.32.12.1780. Antimicrob Agents Chemother. 1988. PMID: 3149884 Free PMC article. Clinical Trial.
At the end of the study, all 29 of the children in the mupirocin group who came to follow-up, compared with 27 of 29 in the erythromycin group, were cured. Side effects were few. Five children in the erythromycin group developed mild diarrhea. ...Our data show a tre …
At the end of the study, all 29 of the children in the mupirocin group who came to follow-up, compared with 27 of 29 in the erythromycin
Clinical and financial impact of intravenous erythromycin therapy in hospitalized patients.
Classen DC, Burke JP, Pestotnik SL, Lloyd JF. Classen DC, et al. Ann Pharmacother. 1999 Jun;33(6):669-73. doi: 10.1345/aph.18251. Ann Pharmacother. 1999. PMID: 10410176 Clinical Trial.
OBJECTIVE: To determine the economic consequences of intravenous erythromycin use in hospital patients in a variety of clinical circumstances. DESIGN: Retrospective cohort study of patients with specified primary diagnosis-related group discharge diagnoses treated from Jan …
OBJECTIVE: To determine the economic consequences of intravenous erythromycin use in hospital patients in a variety of clinical circu …
Clinical safety and tolerance of azithromycin in children.
Hopkins S. Hopkins S. J Antimicrob Chemother. 1993 Jun;31 Suppl E:111-7. doi: 10.1093/jac/31.suppl_e.111. J Antimicrob Chemother. 1993. PMID: 8396082 Review.
The studies compared azithromycin with standard regimens of various comparator agents: co-amoxiclav, amoxycillin, penicillin V, erythromycin, dicloxacillin and flucloxacillin, in the treatment of otitis media, pharyngitis and skin infections. ...
The studies compared azithromycin with standard regimens of various comparator agents: co-amoxiclav, amoxycillin, penicillin V, erythromy
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
Peters DH, Clissold SP. Peters DH, et al. Drugs. 1992 Jul;44(1):117-64. doi: 10.2165/00003495-199244010-00009. Drugs. 1992. PMID: 1379907 Review.
Clarithromycin is an acid-stable orally administered macrolide antimicrobial drug, structurally related to erythromycin. It has a broad spectrum of antimicrobial activity, similar to that of erythromycin and inhibits a range of Gram-positive and Gram-negative organi …
Clarithromycin is an acid-stable orally administered macrolide antimicrobial drug, structurally related to erythromycin. It has a bro …
4,151 results